Glioma Clinical Trials in Omaha, Nebraska

4 studies are recruiting for glioma in Omaha, Nebraska right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

    The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) better than using temozolomide alone in the maintenance setting. Specifically, this study is being done to find answers to the following ques…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Locations
    30 in total
    Run by
    Black Diamond Therapeutics, Inc.

    See if you can join NCT07326566 on ClinicalTrials.gov

  2. Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

    The goal of this interventional study is to evaluate the efficacy of APG-157 in combination with Bevacizumab in subjects with recurrent high-grade glioma. The main questions the study aims to answer are: * Progression-free and overall survival of patients receiving this combination; * Quality of Li…

    Stage
    Phase 1
    Ages
    19 and older
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Locations
    2 in total
    Run by
    Aveta Biomics, Inc.

    See if you can join NCT06011109 on ClinicalTrials.gov

  3. A Study Utilizing Escitalopram in Glioma Patients

    Glioma is a cancer of glial cells, a class of tissue supporting neuronal function in the brain. As many as 85% of glioma patients experience cognitive impairment. This is not only from direct tumor involvement, but also from therapy such as cranial radiation and chemotherapy, which degrades neurona…

    Stage
    Phase 2
    Ages
    19 and older
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Run by
    University of Nebraska

    See if you can join NCT03728673 on ClinicalTrials.gov

  4. ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

    This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with dordaviprone (ONC201) following frontline radiotherapy will extend overall survival and progression-fr…

    Stage
    Phase 3
    Ages
    Any age
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Locations
    162 in total
    Run by
    Jazz Pharmaceuticals

    See if you can join NCT05580562 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.